HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and hematological features of beta(+)-thalassemia (IVS-1 nt 5, G-C mutation) in Thai patients.

Abstract
Seventy-eight patients with IVS-1 nt 5, G-C, which is the common mutation of beta+-thalassemia found in the southern part of Thailand, were studied to determine whether it is possible to predict phenotypic severity from genetic factors. The clinical phenotype of homozygotes for IVS-1 nt 5, G-C and compound heterozygotes for IVS-1 nt 5, G-C and beta(0) - or beta(+)-thalassemia were variable and could not be accurately predicted. The associations between concomittant alpha-thalassemia or Hb CS or the presence of XmnI-Ggamma polymorphism and a mild clinical phenotype are not apparent, indicating the involvement of other ameliorating determinants or genetic modifications.
AuthorsV Laosombat, M Wongchanchailert, B Sattayasevana, A Wiriyasateinkul, S Fucharoen
JournalEuropean journal of haematology (Eur J Haematol) Vol. 67 Issue 2 Pg. 100-4 (Aug 2001) ISSN: 0902-4441 [Print] England
PMID11722597 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobins, Abnormal
  • Globins
  • Hemoglobin Constant Spring
  • endodeoxyribonuclease XmnI
  • Deoxyribonucleases, Type II Site-Specific
Topics
  • Adolescent
  • Alternative Splicing
  • Child
  • DNA Mutational Analysis
  • Deoxyribonucleases, Type II Site-Specific
  • Female
  • Globins (biosynthesis, genetics)
  • Hemoglobinopathies (complications, genetics)
  • Hemoglobins, Abnormal (genetics)
  • Heterozygote
  • Homozygote
  • Humans
  • Male
  • Phenotype
  • Point Mutation
  • Polymorphism, Restriction Fragment Length
  • Severity of Illness Index
  • Thailand (epidemiology)
  • alpha-Thalassemia (complications, genetics)
  • beta-Thalassemia (blood, complications, ethnology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: